Developers of the world's first candidate malaria vaccine said that new tests have shown that it protects a third of six- to 12-week-old infants, which is less than its effect in older babies. The "modest" result came as a surprise to researchers working hard on a drug to combat the mosquito-born disease that kills hundreds of thousands of children per year. The trial vaccine, RTS,S, is made by British pharmaceutical giant GlaxoSmithKline, whose chief ...The Great Place for all lake forest health and fitness | island health and fitness | health and fitness blogs Health and Fitness Blog Information and News.
Saturday, 10 November 2012
Malaria Trial Vaccine Delivers Mixed Results
Developers of the world's first candidate malaria vaccine said that new tests have shown that it protects a third of six- to 12-week-old infants, which is less than its effect in older babies. The "modest" result came as a surprise to researchers working hard on a drug to combat the mosquito-born disease that kills hundreds of thousands of children per year. The trial vaccine, RTS,S, is made by British pharmaceutical giant GlaxoSmithKline, whose chief ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment